MILLA PHARMS FDA Approval ANDA 212405

ANDA 212405

MILLA PHARMS

FDA Drug Application

Application #212405

Application Sponsors

ANDA 212405MILLA PHARMS

Marketing Status

Prescription001

Application Products

001SYRUP;ORAL60MG/5ML0PYRIDOSTIGMINE BROMIDEPYRIDOSTIGMINE BROMIDE

FDA Submissions

UNKNOWN; ORIG1AP2022-04-19STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAA

CDER Filings

MILLA PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212405
            [companyName] => MILLA PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"PYRIDOSTIGMINE BROMIDE","activeIngredients":"PYRIDOSTIGMINE BROMIDE","strength":"60MG\/5ML","dosageForm":"SYRUP;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/19\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-04-19
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.